Cover Image

Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain

Abstract Background HPV cervical cancer screening (CCS) must use validated HPV tests based on the molecular detection of either viral mRNA (Aptima HPV Assay-AHPV) or DNA. AHPV has demonstrated the same cross-sectional and longitudinal sensitivity for the detection of HSIL/CIN2+ lesions but with grea...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. Ibáñez (Author), M. Mareque (Author), R. Granados (Author), D. Andía (Author), M. García-Rojo (Author), J. C. Quílez (Author), I. Oyagüez (Author)
Format:	Book
Published:	BMC, 2021-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
by: Daniel Figueiredo, et al.
Published: (2023)

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain
by: Mareque M, et al.
Published: (2021)

Comparison of detection rate of high risk HPV infection between self-collected HPV testing and clinician-collected HPV testing in cervical cancer screening
by: Pattiya Nutthachote, et al.
Published: (2019)

Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study
by: Marta Trapero-Bertran, et al.
Published: (2017)

Cost-effectiveness analysis study of HPV testing as a primary cervical cancer screening in Thailand
by: Wichai Termrungruanglert, et al.
Published: (2017)

Correction: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
by: Daniel Figueiredo, et al.
Published: (2024)

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum]
by: Mareque M, et al.
Published: (2021)

Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India
by: Surendra S. Shastri, et al.
Published: (2005)

HPV testing for cervical cancer screening in Mozambique: challenges and recommendations
by: Cristina M. de Oliveira, et al.
Published: (2022)

Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
by: R. Ariza, et al.
Published: (2014)

Cost analysis of the use of botulinum toxin type A in Spain
by: F. de Andrés-Nogales, et al.
Published: (2014)

Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain
by: Renata Linertová, et al.
Published: (2022)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022)

Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas
by: Laurence M. Vaughan, et al.
Published: (2019)

The Knowledge and Attitudes of University Students concerning HPV Vaccine and Cervical Screening
by: L Elit, et al.
Published: (2009)

Cost analysis of different cervical cancer screening strategies in Mexico
by: Christyn M Beal, et al.
Published: (2014)

Proposal for cervical cancer screening in the era of HPV vaccination
by: Yung-Taek Ouh, et al.
Published: (2018)

CervicalScreen Norway - A screening programme in transition
by: Tone Bjørge, et al.
Published: (2022)

Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
by: Jesús De La Fuente, et al.
Published: (2019)

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program
by: Jie-Bin Lew, MPH, et al.
Published: (2017)

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
by: Luiz Carlos Zeferino, et al.
Published: (2018)

Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas
by: Marcos Emanuel de Alcântara Segura
Published: (2019)

Cost of the Cervical Cancer Screening Program at the Mexican Social Security Institute
by: Víctor Granados-García, et al.
Published: (2014)

A Cost analysis of multiple triage strategies for early detection of cervical cancer screening programs
by: E. Corona, et al.
Published: (2016)

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: the Morelos HPV study
by: Flores Yvonne, et al.
Published: (2002)

Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand
by: Chayanis Kositamongkol, et al.
Published: (2023)

HPV-FASTER: Combined strategies of HPV vaccination and HPV screening towards a one visit for cervical cancer preventive campaigns (Editorial)
by: F Xavier Bosch, et al.
Published: (2018)

HPV-associated cervical diseases: screening, methods of examination, principles of treatment
by: Vera N Prilepskaya
Published: (2019)

Cervical Screening Using HPV mRNA: A New Modality
by: Nupur Anand, et al.
Published: (2024)

The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening
by: G. Hoste, et al.
Published: (2013)

HPV-based cervical cancer screening in Nicaragua: from testing to treatment
by: Francesca Holme, et al.
Published: (2020)

Utility of Xpert® HPV for cervical cancer screening of HIV-positive women
by: Louise Kuhn
Published: (2017)

Relationship between HPV and HIV. Prevalence, molecular mechanisms and screening of HPV among HIV infected women
by: Katarzyna Kosz, et al.
Published: (2020)

High-Risk HPV Detection in Paraffin-Embedded Tissue from Cervical Lesions
by: Micaela Almeida, et al.
Published: (2024)

Improving cervical cancer screening in Mexico: results from the Morelos HPV Study
by: Flores Yvonne, et al.
Published: (2003)

Sensitivity and Specificity of the SelfAdministered HPV Testing in Detecting Precancerous Conditions of the Cervix and Cervical Cancer
by: Erny M Nyngsi, et al.
Published: (2017)

Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol
by: Julio Cesar Teixeira, et al.
Published: (2020)

Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women
by: Xiaomeng Ma, et al.
Published: (2021)

Modeling the Health Impact and Cost-Effectiveness of a Combined Schoolgirl HPV Vaccination and Cervical Cancer Screening Program in Guangdong Province, China
by: Yating Huang, et al.
Published: (2024)

Health consciousness and cervical cancer screening rates in HPV-unvaccinated girls: comparison from HPV-recommended and HPV-recommendation-suspended program periods
by: Ai Miyoshi, et al.
Published: (2021)